PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma’s (Paris:BIO) shareholders are invited to attend the Combined Ordinary and Extraordinary General Meeting to be held at 2.00 pm on April 29th 2009 at the company’s head office (49 Boulevard du Général Martial Valin, F-75015 Paris, France).
